Live Breaking News & Updates on Health Research Institute

Stay updated with breaking news from Health research institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Chicago , Illinois , United-states , Watertown , American , Randi-isaacs , Josh-rappaport , Ellen-lubman , Justin-moser , American-society-of-clinical-oncology , Scientific-communications , Werewolf-therapeutics-inc

Research In Focus: H-STEM Rising

Research In Focus: H-STEM Rising
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Grand-rapids , Michigan , United-states , Michigan-state-university , Hoda-hatoum , Caryn-heldt , Paul-goetsch , Engineering-the-future-of-human-health , Michigan-state-university-college-of-human-medicine , Health-research , Michigan-tech-health-research-institute , National-science-foundation

Semaglutide Kidney Benefits Extend to Those Without Diabetes

The effects in an obese population without diabetes and low rates of kidney disease suggest a 'potential role in the primary prevention of CKD.' ....

Spain , Edinburgh , City-of , United-kingdom , Stockholm , Sweden , Madrid , Scotland , Helenm-colhoun , University-of-edinburgh , European-renal-association

Semaglutide Significantly Improves Chronic Kidney Disease

The landmark FLOW study shows the benefits extend to kidney, cardiovascular, and mortality outcomes in high-risk patients with type 2 diabetes and CKD. ....

Germany , Australia , Madrid , Spain , Sydney , New-south-wales , Stockholm , Sweden , Vlado-perkovic , Alberto-ortiz , Katheriner-tuttle , Christoph-wanner